POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
A randomized, multi-center, double-blind, proof-of-concept study to assess the effect of
 multiple infusions of AIN457 (10 mg/kg) versus placebo on disease activity as measured by MRI
 scans over a 24 week period in patients with relapsing-remitting multiple sclerosis
Inclusion Criteria:

 -

 Exclusion Criteria:

 -